BUUU Group Limited has approved a 10-for-1 forward stock split, subdividing each Class A and B ordinary share into ten shares to make its stock more accessible and enhance trading liquidity. The split will take effect on October 26, 2026, subject to Nasdaq processing, with shares continuing to trade under the symbol BUUU. This move follows BUUU's recent acquisition of a 60% stake in Brightray Science Inc., focusing on AI data center delivery as its core growth business. Shareholders need not take action unless holding physical certificates, and the split will not change voting rights or ownership percentages.
BUUU Group Limited's 10-for-1 forward share split is noted here with a snapshot of the Technology sector on Pluang as of Oct 17, 2026 03:31 WIB. Among 150 priced US tech stocks, 27 rose and 122 fell. For comparison, AEHR dropped 12.30% to USD 60.70 with 80% buy orders and a typical hold time of 16 days, while NBIS declined 11.46% to USD 166.82 with a 59% buy ratio and 25 days hold. In contrast, KD gained 11.28% to USD 13.12, seeing 100% buy orders and a longer hold time of 36 days.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
